ProHealth health Resource
 SUBSCRIBE TO OUR FREE E-NEWSLETTERS  
Click Here to Preview
Log In
Catalog Quick Order
Your Account
Shopping Cart
 Check Out
ProHealth: News, Research, Vitamins & Supplements About ProHealth ProHealth ImmuneSupport.com ProHealth Online Vitamin & Supplement Store ProHealth Treatment & Research Library ProHealth Community ProHealth Vitamins & Supplements Catalog
Your Purchase Helps Fund Health Research
Celebrating 20 Years
Explore Our Health Sites
ProHealth Vitamin and Supplement Catalog
Your resource for specialty nutritional supplements, books, DVDs, resources for better living, health news & more!
ProHealth Health & Wellness Research & News Catalog
Your Purchases Help Fund Ongoing Research
 
 
Search our extensive library for information, solutions & support
Site
Message Board  
Abstracts
Newsletters  
Articles
Products  

Abstract: Prognosis of Chronic Fatigue [Syndrome] in a Community-Based Sample

March 28, 2002


Journal: Psychosom Med 2002 Mar-Apr;64(2):319-27

Authors: Taylor RR, Jason LA, Curie CJ.

Affiliation: Department of Psychology, DePaul University, Chicago, IL.

NLM Citation: PMID: 11914449

OBJECTIVE: This study examined predictors of fatigue severity and predictors of continued chronic fatigue status at wave 2 follow-up within a random, community-based sample of individuals previously evaluated in a wave 1 prevalence study of chronic fatigue and chronic fatigue syndrome that originally took place between 1995 and 1997.

METHODS: Wave 1 data were from a larger community-based prevalence study of chronic fatigue syndrome. In the present study, a second wave of data were collected by randomly selecting a sample of participants from the wave 1 sample of 18,675 adults and readministering a telephone screening questionnaire designed to assess symptoms of chronic fatigue syndrome.

RESULTS: Findings revealed that wave 1 fatigue severity was a predictor of fatigue severity at wave 2 in the overall sample of individuals with and without chronic fatigue. In the smaller sample of individuals with chronic fatigue, wave 1 fatigue severity, worsening of fatigue with physical exertion, and feeling worse for 24 hours or more after exercise significantly predicted continued chronic fatigue status (vs.
improvement) at wave 2 follow-up.

CONCLUSIONS: These findings underscore the prognostic validity of postexertional malaise in predicting long-term chronic fatigue and also highlight the importance of using population-based, representative random samples when attempting to identify long-term predictors of chronic fatigue at follow-up.

Discussion:

The present study examined predictors of fatigue severity and continued CF status at wave 2 follow-up within a random community-based sample of individuals previously evaluated in a prevalence study (6, 11). Fifty percent of control subjects and 76.1% of individuals with CF randomly selected for interview from the wave 1 study (6, 11) were contacted and administered a follow-up telephone screening questionnaire assessing changes in fatigue severity, fatigue-related symptomatology, and emotional distress. These completion rates are comparable with rates from other community-based follow-up studies (36–38). To identify wave 1 predictors of fatigue severity at wave 2 follow-up, a series of simple univariate analyses were conducted comparing individuals with and without CF. Findings revealed significant differences between the CF and control groups with respect to wave 1 fatigue severity (23), age, marital status, disability status, and effects of fatigue on usual daily activities.

However, when the effects of each of these variables over and above wave 1 fatigue severity were tested separately as potential predictors of fatigue severity at wave 2 follow-up, none emerged as significant predictors. Thus, wave 1 fatigue severity was the only variable that significantly predicted fatigue severity at wave 2 in the overall sample of individuals with CF and control subjects. In part, these results are consistent with findings from prior studies of mixed populations, which have identified markers of more severe illness, such as fatigue severity and more severe disability, as predictors of poorer outcome (8). However, in contrast to prior reports of increasing age and changing or leaving employment as predictors of poorer outcome (8, 19), age and unemployment status did not emerge as significant predictors of fatigue severity at the wave 2 follow-up in the present study.

A number of variables were associated with significant differences between individuals with CF who remained fatigued at follow-up (fatigued group) and those who no longer had CF (improved group). These included work status, wave 1 fatigue severity (23), worsening of fatigue with physical exertion, past-month functional capacity, GHQ index of emotional distress, the frequency of eight minor CFS symptoms (7), postexertional malaise for 24 hours or more, joint pain, and unrefreshing sleep. However, when the effects of these variables on wave 2 fatigue status were examined, not in isolation but in relation to wave 1 fatigue severity, results of logistic regression analysis indicated that wave 1 fatigue severity, worsening of fatigue with physical exertion, and postexertional malaise for 24 hours or more were the only significant predictors of continued CF status at the wave 2 follow-up. With the exception of wave 1 fatigue severity predicting continued CF status, these results contrast with those of prior studies, which highlight the relationships between age, illness duration, illness attributions, and fatigue at follow-up (8).

In part, differences observed between this study and prior studies may stem from the use of different sampling methodologies between studies. Our sample was generated using randomized, population-based sampling methods, whereas a number of previous studies have used samples of convenience, such as tertiary care clinic samples. In contrast to clinic samples, which tend to be biased in terms of ethnic homogeneity, use of medical care, age (typically over 30), and tendency toward medical attribution for symptoms (18, 22), the random community population we sampled was more heterogeneous in terms of these variables and likely more representative of the general population. In addition, although most other studies have used correlational analyses (19) or have reported basic proportional and percentage data (39), the present study analyzed multivariate relationships in predicting outcome at follow-up.

In the present study, the contrast in the abundance of significant findings when simple univariate analyses were used as compared with fewer findings when regression analyses were used underscores the importance of considering multivariate relationships when generating conclusions about predictors of outcome in investigations of CF.

Findings for the significance of postexertional malaise in predicting continued fatigue status at follow-up can be interpreted as supporting the prognostic validity of this symptom in predicting long-term CF and should be considered in the future design of measures to assess characteristics of illnesses involving CF. In a recent study, Jason and Taylor (40) found that postexertional malaise was the single most important factor in discriminating CFS and medically explained CF from idiopathic CF.

In addition, postexertional malaise also discriminated medically explained CF from psychiatrically explained CF (40). Thus, fatigue resulting from physical exertion not only seems to be a key discriminator of more severe fatigue-related illnesses, but also seems to be an important prognostic indicator of poorer outcome at follow-up.

This study had a number of limitations. One central limitation was the small sample size, which required us to conduct a series of univariate analyses to select variables for the predictive model, thereby limiting the extent to which multivariate statistics could be used. Another limitation that, in part, contributed to the small sample size was the lower follow-up completion rate of 50% for the control sample. Although most follow-up studies of CF are characterized by small sample size (8) and our 50% rate was higher than that found in other large-scale, community-based follow-up studies (36–38), it was lower than the rate we achieved for the CF sample (76.1%).

It is possible that individuals in the control sample were less likely to participate because of lack of interest in the subject matter of fatigue. This was a preliminary investigation, and as such the initial follow-up sample targeted for interview was small. It would be important to test and replicate these findings in a future study involving the entire wave 1 sample of 18,675 individuals. In addition, measures of some variables found to be predictors of fatigue in previous studies, such as categorical measures of the presence vs. absence of psychiatric disorder, were not included in the present study.

In summary, results from the present investigation support the validity of fatigue severity (23) both as a predictor of fatigue severity at follow-up within a mixed sample of individuals with and without CF and also as a predictor of continued CF status among a sample of individuals with CF only. In contrast to findings from prior studies (8), findings from the present investigation also underscore the validity of postexertional malaise as a predictor of continued CF within a sample of individuals with CF. Differences in findings between the present study and previous studies not only highlight the importance of using random community-based sampling procedures when conducting epidemiological research, but also emphasize the utility of multivariate and logistic regression procedures in accurately testing and identifying predictors of outcome. (41–44)




DISCUSS THIS ARTICLE   (0 existing comments) Post a Comment 
health Research Articles



[ Be the first to comment on this article ]




<i>Abstract</i>: Prognosis of Chronic Fatigue [Syndrome] in a Community-Based Sample Article Tools
Print Page Print Page Email Article Email Article
Discuss Discuss
  Rate This
Featured Vitamins, Supplements, and Health Products
Immune/Energy Value Pack    Immune/Energy Value Pack
Detoxify and boost energy with NT Factor
Pro Energy Pro Energy
Increase energy and promote muscle health
Transfer Factor Essentials™ Transfer Factor Essentials™
Transfer factor strengthens the foundation of immune system health
Energy NADH™ 5mg Energy NADH™ 5mg
Long-lasting energy, without stimulants
Pure Guai™ Pure Guai™
If you need product before this is available consider this as a replacement: Guaifenesin FA™
Most Viewed Articles & Abstracts
CFS Advisory Committee Meeting - Live Online Oct 29-30 [more]

Flu – What Is It That Stops Many People from Getting It? [more]

Body manufactures potent anti-inflammatory using DHA in fish oils - discovery holds much promise [more]

Intimacy - What to Do When ME/CFS or FM Becomes a Third Wheel in Your Relationship [more]

Dr. Charles Shepherd Updates His Advisory on Swine Flu & the Vaccine for ME/CFS Patients – A Highly ... [more]

ProHealth Vitamin and Supplement SmartSavings Club
Security Enabled AlertSite is a leading provider of Web site monitoring and performance management solutions that help businesses ensure optimum Web experiences for their customers. TrustE Better Business Bureau BizRate Customer Certified (GOLD) Site

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
ADVANCED MEDICAL LABS   |   WHOLESALE   |   AFFILIATES   |   CONTACT US   |   PRIVACY   |   GLOSSARY   |   CUSTOMER SERVICE   |   RELATED SITES   |   RSS
Email us or Call toll-free 800-366-6056 · Monday through Friday, 7 a.m.-5 p.m. Pacific Time
International Callers dial 001.805.564.3064
Copyright © 2009 ProHealth, Inc.